Svizera Holdings

Svizera Holdings is a global pharmaceutical group specialized in the development, manufacturing, and supply of products for the treatment and diagnosis of infectious diseases, with a primary focus on Tuberculosis (TB). The company operates as a key partner to international health organizations, including the World Health Organization (WHO) and the Global Drug Facility (GDF), providing essential first-line and second-line anti-TB medications. Beyond therapeutics, Svizera offers a range of diagnostic solutions, laboratory equipment, and specialized "Patient Kits" designed to improve treatment adherence in resource-limited settings. With headquarters in the Netherlands and manufacturing facilities in India, the company maintains a robust supply chain reaching over 100 countries. Their business model integrates R&D, large-scale GMP manufacturing, and global logistics to address public health crises.